Prelude Capital Management, LLC Senseonics Holdings, Inc. Call Options Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.94 - $1.94 $2,444 - $5,044	-2,600 Reduced 0.84%	307,600 $317,000
Q1 2022 May 16, 2022	SELL	$1.54 - $3.71 $770 - $1,855	-500 Reduced 0.16%	310,200 $611,000
Q4 2021 Feb 14, 2022	BUY	$2.58 - $3.91 $198,402 - $300,679	76,900 Added 32.89%	310,700 $830,000
Q3 2021 Nov 15, 2021	BUY	$2.77 - $4.05 $160,660 - $234,900	58,000 Added 32.99%	233,800 $793,000
Q2 2021 Aug 16, 2021	SELL	$1.71 - $4.14 $25,650 - $62,099	-15,000 Reduced 7.86%	175,800 $675,000
Q1 2021 May 17, 2021	BUY	$0.85 - $5.27 $162,180 - $1.01 Million	190,800 New	190,800 $504,000

137

60M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $526M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.